Logo image of ATS

ATS CORP (ATS) Stock Fundamental Analysis

NYSE:ATS - CA00217Y1043 - Common Stock

27.72 USD
+0.17 (+0.62%)
Last: 8/29/2025, 8:07:14 PM
27.72 USD
0 (0%)
After Hours: 8/29/2025, 8:07:14 PM
Fundamental Rating

3

Taking everything into account, ATS scores 3 out of 10 in our fundamental rating. ATS was compared to 128 industry peers in the Machinery industry. Both the profitability and financial health of ATS have multiple concerns. ATS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ATS had positive earnings in the past year.
ATS had a positive operating cash flow in the past year.
Of the past 5 years ATS 4 years were profitable.
In the past 5 years ATS always reported a positive cash flow from operatings.
ATS Yearly Net Income VS EBIT VS OCF VS FCFATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.89%, ATS is doing worse than 71.88% of the companies in the same industry.
ATS has a worse Return On Equity (-2.30%) than 71.09% of its industry peers.
The Return On Invested Capital of ATS (1.59%) is worse than 70.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ATS is below the industry average of 9.99%.
The last Return On Invested Capital (1.59%) for ATS is well below the 3 year average (6.08%), which needs to be investigated, but indicates that ATS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.89%
ROE -2.3%
ROIC 1.59%
ROA(3y)2.58%
ROA(5y)2.92%
ROE(3y)7.06%
ROE(5y)8.16%
ROIC(3y)6.08%
ROIC(5y)6.21%
ATS Yearly ROA, ROE, ROICATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

ATS has a Operating Margin of 2.62%. This is in the lower half of the industry: ATS underperforms 70.31% of its industry peers.
In the last couple of years the Operating Margin of ATS has declined.
ATS has a worse Gross Margin (25.92%) than 63.28% of its industry peers.
In the last couple of years the Gross Margin of ATS has remained more or less at the same level.
Industry RankSector Rank
OM 2.62%
PM (TTM) N/A
GM 25.92%
OM growth 3Y-30.58%
OM growth 5Y-19.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.77%
GM growth 5Y0.22%
ATS Yearly Profit, Operating, Gross MarginsATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ATS is destroying value.
Compared to 1 year ago, ATS has less shares outstanding
ATS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATS has a worse debt to assets ratio.
ATS Yearly Shares OutstandingATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ATS Yearly Total Debt VS Total AssetsATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

ATS has an Altman-Z score of 1.85. This is not the best score and indicates that ATS is in the grey zone with still only limited risk for bankruptcy at the moment.
ATS has a Altman-Z score of 1.85. This is in the lower half of the industry: ATS underperforms 67.97% of its industry peers.
ATS has a debt to FCF ratio of 10.97. This is a negative value and a sign of low solvency as ATS would need 10.97 years to pay back of all of its debts.
ATS has a Debt to FCF ratio of 10.97. This is in the lower half of the industry: ATS underperforms 62.50% of its industry peers.
ATS has a Debt/Equity ratio of 0.87. This is a neutral value indicating ATS is somewhat dependend on debt financing.
ATS has a worse Debt to Equity ratio (0.87) than 75.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.97
Altman-Z 1.85
ROIC/WACC0.16
WACC9.68%
ATS Yearly LT Debt VS Equity VS FCFATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

ATS has a Current Ratio of 1.62. This is a normal value and indicates that ATS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.62, ATS is doing worse than 70.31% of the companies in the same industry.
ATS has a Quick Ratio of 1.32. This is a normal value and indicates that ATS is financially healthy and should not expect problems in meeting its short term obligations.
ATS has a Quick ratio (1.32) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.32
ATS Yearly Current Assets VS Current LiabilitesATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

5

3. Growth

3.1 Past

ATS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.80%.
ATS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.90% yearly.
ATS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.38%.
ATS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.12% yearly.
EPS 1Y (TTM)-42.8%
EPS 3Y-11.98%
EPS 5Y6.9%
EPS Q2Q%-18%
Revenue 1Y (TTM)-13.38%
Revenue growth 3Y5.09%
Revenue growth 5Y12.12%
Sales Q2Q%6.11%

3.2 Future

The Earnings Per Share is expected to grow by 21.89% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.18% on average over the next years. This is quite good.
EPS Next Y25.7%
EPS Next 2Y25.83%
EPS Next 3Y21.89%
EPS Next 5YN/A
Revenue Next Year11.64%
Revenue Next 2Y8.92%
Revenue Next 3Y8.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ATS Yearly Revenue VS EstimatesATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
ATS Yearly EPS VS EstimatesATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.45, ATS can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as ATS.
Compared to an average S&P500 Price/Earnings ratio of 27.13, ATS is valued at the same level.
The Price/Forward Earnings ratio is 16.27, which indicates a correct valuation of ATS.
ATS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ATS is cheaper than 70.31% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ATS to the average of the S&P500 Index (22.76), we can say ATS is valued slightly cheaper.
Industry RankSector Rank
PE 27.45
Fwd PE 16.27
ATS Price Earnings VS Forward Price EarningsATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ATS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ATS is more expensive than 67.97% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as ATS.
Industry RankSector Rank
P/FCF 26.87
EV/EBITDA 22.95
ATS Per share dataATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ATS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ATS's earnings are expected to grow with 21.89% in the coming years.
PEG (NY)1.07
PEG (5Y)3.98
EPS Next 2Y25.83%
EPS Next 3Y21.89%

0

5. Dividend

5.1 Amount

No dividends for ATS!.
Industry RankSector Rank
Dividend Yield N/A

ATS CORP

NYSE:ATS (8/29/2025, 8:07:14 PM)

After market: 27.72 0 (0%)

27.72

+0.17 (+0.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners97.4%
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap2.71B
Analysts76.67
Price Target34.24 (23.52%)
Short Float %3.79%
Short Ratio27.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.26%
Min EPS beat(2)-2.83%
Max EPS beat(2)9.34%
EPS beat(4)1
Avg EPS beat(4)-4.31%
Min EPS beat(4)-22.3%
Max EPS beat(4)9.34%
EPS beat(8)2
Avg EPS beat(8)-1.09%
EPS beat(12)4
Avg EPS beat(12)1.58%
EPS beat(16)8
Avg EPS beat(16)7.14%
Revenue beat(2)1
Avg Revenue beat(2)-7.46%
Min Revenue beat(2)-17.23%
Max Revenue beat(2)2.32%
Revenue beat(4)1
Avg Revenue beat(4)-5.29%
Min Revenue beat(4)-17.23%
Max Revenue beat(4)2.32%
Revenue beat(8)4
Avg Revenue beat(8)-1.39%
Revenue beat(12)7
Avg Revenue beat(12)0.01%
Revenue beat(16)10
Avg Revenue beat(16)1.04%
PT rev (1m)-1.4%
PT rev (3m)-5.24%
EPS NQ rev (1m)-6.53%
EPS NQ rev (3m)-24.16%
EPS NY rev (1m)-11.26%
EPS NY rev (3m)-11.26%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 27.45
Fwd PE 16.27
P/S 1.45
P/FCF 26.87
P/OCF 17.16
P/B 2.18
P/tB N/A
EV/EBITDA 22.95
EPS(TTM)1.01
EY3.64%
EPS(NY)1.7
Fwd EY6.15%
FCF(TTM)1.03
FCFY3.72%
OCF(TTM)1.62
OCFY5.83%
SpS19.18
BVpS12.71
TBVpS-3.05
PEG (NY)1.07
PEG (5Y)3.98
Profitability
Industry RankSector Rank
ROA -0.89%
ROE -2.3%
ROCE 2.02%
ROIC 1.59%
ROICexc 1.68%
ROICexgc 5.11%
OM 2.62%
PM (TTM) N/A
GM 25.92%
FCFM 5.38%
ROA(3y)2.58%
ROA(5y)2.92%
ROE(3y)7.06%
ROE(5y)8.16%
ROIC(3y)6.08%
ROIC(5y)6.21%
ROICexc(3y)6.47%
ROICexc(5y)6.7%
ROICexgc(3y)21.12%
ROICexgc(5y)23.22%
ROCE(3y)7.75%
ROCE(5y)7.9%
ROICexcg growth 3Y-44.72%
ROICexcg growth 5Y-24.75%
ROICexc growth 3Y-37.32%
ROICexc growth 5Y-25.02%
OM growth 3Y-30.58%
OM growth 5Y-19.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.77%
GM growth 5Y0.22%
F-Score3
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.97
Debt/EBITDA 6.75
Cap/Depr 51.43%
Cap/Sales 3.05%
Interest Coverage 0.73
Cash Conversion 98.59%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.32
Altman-Z 1.85
F-Score3
WACC9.68%
ROIC/WACC0.16
Cap/Depr(3y)59.25%
Cap/Depr(5y)53.7%
Cap/Sales(3y)3.04%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.8%
EPS 3Y-11.98%
EPS 5Y6.9%
EPS Q2Q%-18%
EPS Next Y25.7%
EPS Next 2Y25.83%
EPS Next 3Y21.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.38%
Revenue growth 3Y5.09%
Revenue growth 5Y12.12%
Sales Q2Q%6.11%
Revenue Next Year11.64%
Revenue Next 2Y8.92%
Revenue Next 3Y8.18%
Revenue Next 5YN/A
EBIT growth 1Y-79.35%
EBIT growth 3Y-27.04%
EBIT growth 5Y-9.42%
EBIT Next Year55.73%
EBIT Next 3Y21.43%
EBIT Next 5YN/A
FCF growth 1Y452.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y319.6%
OCF growth 3Y-50.79%
OCF growth 5Y4.89%